Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Public ClinicalTrials.gov record NCT00302016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multicenter, Expanded Access Study of Oral AMN107 in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase, or Chronic Phase.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will further evaluate if AMN107 is safe in adults with chronic myeloid leukemia who are resistant or intolerant to imatinib and to provide patients access to this new drug until the drug becomes commercially available.
Study identification
- NCT ID
- NCT00302016
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2005
- Primary completion
- Oct 31, 2008
- Completion
- Not listed
- Last update posted
- Aug 25, 2011
Started 2006
United States locations
- U.S. sites
- 59
- U.S. states
- 30
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Cancer Research Institute | Mobile | Alabama | 36693 | — |
| Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| Antelope Valley Cancer Center | Lancaster | California | 93534 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| University of Colorado | Aurora | Colorado | 80010 | — |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | — |
| Georgetown University Medical Center-Lombardi Cancer Center | Washington D.C. | District of Columbia | 20007-2113 | — |
| Washington Cancer Institute | Washington D.C. | District of Columbia | 20010 | — |
| Osler Medical Inc./Osler Clinical Research | Melbourne | Florida | 32901 | — |
| Advanced Medical Specialties | Miami | Florida | 33176 | — |
| Integrated Community | Orange Park | Florida | 32073 | — |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | — |
| MD Anderson Cancer Center | Orlando | Florida | 32806 | — |
| Hematology Oncology Assoc. | Pensacola | Florida | 32501 | — |
| Emory University Cancer Institute | Atlanta | Georgia | 30322 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Stroger Cook County Hospital | Chicago | Illinois | 60612 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| University of Chicago Hospital | Chicago | Illinois | 60637 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| St. Francis Hospital & Health Centers | Beech Grove | Indiana | 46107 | — |
| University of Iowa Hospitals & Clinics | Iowa City | Iowa | 52242 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Louisville Oncology Research | Louisville | Kentucky | 40202 | — |
| LSU Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| St. Agnes Hospital | Baltimore | Maryland | 21229 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| St. John Hospital and Medical Center | Grosse Pointe | Michigan | 48236 | — |
| Mayo Clinic Hospital | Rochester | Minnesota | 55905 | — |
| Southeast Nebraska Cancer Center | Lincoln | Nebraska | 68516 | — |
| Nebraska Methodist Cancer Center | Omaha | Nebraska | 68114 | — |
| Nevada Cancer Institute | Las Vegas | Nevada | 89135 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| University of New Mexico Health Sciences Center | Albuquerque | New Mexico | 87131 | — |
| Cancer Institute of New Mexico | Santa Fe | New Mexico | 87505 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Winthrop Hematology/Oncology | Mineola | New York | 11501 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10017 | — |
| Weill Cornell Medical Center | New York | New York | 10021 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Cancer Care Associates | Oklahoma City | Oklahoma | 734112 | — |
| Cancer Care Associates | Tulsa | Oklahoma | 74136 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| Western Pennsylvania Cancer Institute | Pittsburgh | Pennsylvania | 15224 | — |
| Charleston Hematology Oncology | Charleston | South Carolina | 29403 | — |
| MUSC Hollings Cancer Center | Charleston | South Carolina | 29425 | — |
| Three Medical Park | Columbia | South Carolina | 29203 | — |
| Cancer Center of the Carolinas | Greenville | South Carolina | 29615 | — |
| The Jones Clinic | Germantown | Tennessee | 38138 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 211 non-U.S. sites.
Recently updated Chronic Myeloid Leukemia trials
Other public records listing Chronic Myeloid Leukemia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07758218: Allogeneic iNKT Cell Therapy (agenT-797) After SCT Not yet recruiting
- NCT04013685: Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies Active, not recruiting
- NCT03326921: HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant Recruiting
- NCT06236724: Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. Recruiting
- NCT05334069: Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection Recruiting
- NCT07269470: Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00302016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2011 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00302016 live on ClinicalTrials.gov.